Olympus (FRA:OLY1) Valuation Rank


FRA:OLY1 Olympus Corp FRA:OLY1
81 GF Score
Price €9.59
GF Value €13.92
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Olympus Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Olympus Valuation Rank Related Terms

FRA:OLY1
81GF Score
Olympus Corp FRA:OLY1
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Olympus (FRA:OLY1) Overvalued in 2026?

Based on GuruFocus' analysis, Olympus stock appears to be undervalued. The current stock price of €9.59 is trading 31.1% below its estimated GF Value™ of €13.92. GuruFocus considers Olympus to be Significantly Undervalued.

Key valuation signals for FRA:OLY1:

  • Valuation Rank:
  • GF Value™: €13.92 vs. price of €9.59 (31.1% below fair value)
  • GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the FRA:OLY1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Olympus Business Description

Address 2951 Ishikawacho, Hachioji, JPN, 192-8507
Olympus is a medical-device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2025, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.
81GF Score

Get the complete analysis for FRA:OLY1

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.59
Price
€13.92
GF Value